HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael J Welch Selected Research

Prostatic Neoplasms (Prostate Cancer)

10/2012Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging.
1/2011Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models.
3/2007Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.
8/2006Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide.
7/2006Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F]fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide.
3/2005Positron tomographic assessment of androgen receptors in prostatic carcinoma.
3/2004Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
7/2003MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.
11/2002MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael J Welch Research Topics

Disease

48Neoplasms (Cancer)
01/2016 - 01/2002
18Breast Neoplasms (Breast Cancer)
11/2012 - 11/2002
15Hypoxia (Hypoxemia)
05/2010 - 03/2002
9Prostatic Neoplasms (Prostate Cancer)
10/2012 - 11/2002
7Carcinoma (Carcinomatosis)
01/2012 - 04/2003
5Asthma (Bronchial Asthma)
09/2016 - 01/2004
4Melanoma (Melanoma, Malignant)
05/2009 - 04/2005
4Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2008 - 04/2003
3Inflammation (Inflammations)
10/2013 - 01/2012
3Atherosclerosis
07/2013 - 01/2010
3Diabetic Cardiomyopathies
08/2008 - 01/2002
3Cardiomyopathies (Cardiomyopathy)
12/2007 - 01/2002
2Type 2 Diabetes Mellitus (MODY)
09/2009 - 08/2008
2Ischemia
01/2009 - 12/2007
2Necrosis
07/2005 - 11/2002
1Peanut Hypersensitivity (Peanut Allergy)
11/2018
1Vascular System Injuries
07/2013
1Adenocarcinoma
01/2012
1Carcinogenesis
01/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2011
1Glioblastoma (Glioblastoma Multiforme)
02/2011

Drug/Important Bio-Agent (IBA)

11LigandsIBA
10/2012 - 03/2002
9Estrogen ReceptorsIBA
11/2012 - 05/2003
8RadiopharmaceuticalsIBA
11/2012 - 08/2002
7Glucose (Dextrose)FDA LinkGeneric
05/2010 - 01/2002
7copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
08/2008 - 11/2002
6Progesterone Receptors (Progesterone Receptor)IBA
07/2012 - 07/2006
51,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2016 - 09/2004
5Peptides (Polypeptides)IBA
02/2011 - 07/2003
4Hormones (Hormone)IBA
07/2012 - 10/2005
4Estrogens (Estrogen)FDA Link
07/2012 - 03/2005
4Biomarkers (Surrogate Marker)IBA
07/2012 - 06/2006
4CopperIBA
06/2011 - 03/2002
4Acetates (Acetic Acid Esters)FDA Link
10/2009 - 02/2002
4alpha-MSHIBA
05/2009 - 04/2005
4Biological ProductsIBA
04/2009 - 08/2003
4Androgen Receptors (Androgen Receptor)IBA
03/2007 - 03/2005
4AndrogensIBA
03/2007 - 11/2002
4Radioisotopes (Radionuclides)IBA
07/2005 - 08/2003
3Monoclonal AntibodiesIBA
01/2016 - 08/2003
3Pharmaceutical PreparationsIBA
10/2013 - 07/2005
3Progestins (Progestagens)IBA
07/2012 - 07/2006
3Estradiol (Delestrogen)FDA LinkGeneric
07/2012 - 11/2003
3PPAR gammaIBA
01/2012 - 10/2006
3IntegrinsIBA
02/2011 - 09/2004
3LipidsIBA
10/2009 - 02/2005
3Oxygen (Dioxygen)IBA
10/2009 - 05/2004
3Deoxyglucose (2 Deoxy D glucose)IBA
02/2009 - 09/2003
3PPAR alphaIBA
12/2007 - 01/2002
3Fatty Acids (Saturated Fatty Acids)IBA
12/2007 - 01/2002
3RheniumIBA
11/2007 - 11/2003
3Folic Acid (Vitamin M)FDA LinkGeneric
06/2006 - 10/2003
2Proteins (Proteins, Gene)FDA Link
11/2018 - 08/2008
2SteroidsIBA
07/2012 - 01/2012
2Atrial Natriuretic Factor (ANF)IBA
12/2011 - 01/2010
2Natriuretic PeptidesIBA
12/2011 - 01/2010
2Therapeutic UsesIBA
01/2011 - 03/2004
2Carbon-11IBA
12/2010 - 07/2005
2GoldIBA
11/2010 - 04/2010
2Chelating AgentsIBA
05/2009 - 04/2009
2MetalsIBA
05/2009 - 11/2003
2Integrin beta3 (GPIIIa)IBA
04/2009 - 09/2004
2fluoromisonidazoleIBA
08/2008 - 04/2005
2Fluticasone (Cutivate)FDA LinkGeneric
01/2008 - 01/2004
2benzamideIBA
07/2007 - 06/2006
21,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA
01/2007 - 04/2005
2Estrogen Receptor alphaIBA
10/2005 - 05/2003
2Estrogen Receptor betaIBA
10/2005 - 05/2003
2Technetium (Technetium 99m)IBA
03/2005 - 11/2003
2ThiosemicarbazonesIBA
02/2005 - 03/2002
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2002 - 01/2002
1Albuterol (Salbutamol)FDA LinkGeneric
09/2016
1patritumabIBA
01/2016
1Somatostatin Receptors (Somatostatin Receptor)IBA
10/2013
1Apolipoproteins E (ApoE)IBA
07/2013
1ApolipoproteinsIBA
07/2013
1(64)Cu-DOTA-vMIP-IIIBA
07/2013
1ChemokinesIBA
07/2013
1Chemokine ReceptorsIBA
07/2013
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2013
1HaptoglobinsIBA
10/2012
1Fulvestrant (Faslodex)FDA Link
07/2012
1Indicators and Reagents (Reagents)IBA
07/2012
1ProgesteroneFDA LinkGeneric
03/2012
1STAT Transcription FactorsIBA
01/2012
1Phenobarbital (Luminal)FDA Link
01/2012
1conatumumabIBA
06/2011
1Trastuzumab (Herceptin)FDA Link
04/2011
1Docetaxel (Taxotere)FDA Link
01/2011
1SurvivinIBA
12/2010
1LY 2181308IBA
12/2010
1Antisense OligonucleotidesIBA
12/2010

Therapy/Procedure

25Therapeutics
11/2012 - 01/2002
11Radiotherapy
02/2011 - 04/2003
4Drug Therapy (Chemotherapy)
11/2008 - 04/2003
1Immunotherapy
11/2018
1Nebulizers and Vaporizers (Inhaler)
09/2016
1Dry Powder Inhalers
09/2016
1Precision Medicine
04/2012